Facebook
Twitter
LinkedIn
Forward
We are amidst a paradigm shift in obesity treatment, spurred by the introduction of newer, highly effective anti-obesity medications.
|
In this session, co-presented by a primary care and an obesity-focused tertiary care provider, we will review barriers and facilitators to pediatric obesity treatment in primary and tertiary care s
|
70% of Americans have pre-obesity or the serious, chronic, and relapsing disease of obesity.
|
This session covers the employer health benefit landscape and how it has changed over the last five years due to COVID, new treatments, technology, and competition.
|
This session will discuss strategies to increase access to obesity care while mitigating provider burnout.
|
This webinar will provide foundational information on Shared Medical Appointments (a.k.a group medical visits), which are a reimbursable evidence-based care delivery stra
|
This presentation will provide clinicians a brief scientific overview of 10 of the most controversial topics covered, discussed, and published in OMA’s Clinical Practice Statements, including:
|
This presentation discusses the particular administrative needs and challenges related to treating obesity.
|
The presentation will educate the attendees on how to decide on a transition from a primary care medical practice to a full-fledged obesity medicine practice.
|
Obesity Medicine 2023 - Spring Obesity Summit
|